S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Global shares mostly rise after House approves debt ceiling deal
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Global shares mostly rise after House approves debt ceiling deal
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Global shares mostly rise after House approves debt ceiling deal
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
S&P 500   4,179.83
DOW   32,908.27
QQQ   347.99
Stock market today: Global shares mostly rise after House approves debt ceiling deal
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Alibaba Unveils Its Spin-Off Plans
The Most Upgraded Stocks From The Q1 Earnings Season
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Oman launches $5B investment fund as part of efforts to diversify oil-dependant economy
Can the Dow's 2023 Runaway Winners Keep Running?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
KLA Shares Soars As Chip Equipment Makers Surge 21% In May
Can These Two Crypto Stocks Stage a Comeback?
NYSE:AMPE

Ampio Pharmaceuticals (AMPE) Stock Forecast, Price & News

$0.31
+0.02 (+6.93%)
(As of 05/31/2023 ET)
Compare
Today's Range
$0.29
$0.31
50-Day Range
N/A
52-Week Range
$0.18
$3.94
Volume
117,906 shs
Average Volume
288,406 shs
Market Capitalization
$4.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.

Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMPE Stock News Headlines

See More Headlines
Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMPE Company Calendar

Today
5/31/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-16,340,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.52 per share

Miscellaneous

Free Float
14,970,000
Market Cap
$4.66 million
Optionable
Optionable
Beta
1.81

Key Executives

  • Michael A. Martino
    Chief Executive Officer & Director
  • Daniel G. Stokely
    Chief Financial Officer & Secretary
  • Howard Levy
    Chief Medical Officer
  • Lane Hapke
    Vice President-Manufacturing Operations
  • Laura Goldberg
    Vice President-Quality & Regulatory Operations













AMPE Stock - Frequently Asked Questions

How have AMPE shares performed in 2023?

Ampio Pharmaceuticals' stock was trading at $0.2863 at the start of the year. Since then, AMPE shares have increased by 7.8% and is now trading at $0.3085.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Ampio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Tesla (TSLA), Agenus (AGEN) and American Airlines Group (AAL).

What is Ampio Pharmaceuticals' stock symbol?

Ampio Pharmaceuticals trades on the New York Stock Exchange (NYSE) under the ticker symbol "AMPE."

How do I buy shares of Ampio Pharmaceuticals?

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ampio Pharmaceuticals' stock price today?

One share of AMPE stock can currently be purchased for approximately $0.31.

How much money does Ampio Pharmaceuticals make?

Ampio Pharmaceuticals (NYSE:AMPE) has a market capitalization of $4.66 million.

How can I contact Ampio Pharmaceuticals?

Ampio Pharmaceuticals' mailing address is 373 INVERNESS PARKWAY SUITE 200, ENGLEWOOD CO, 80112. The official website for the company is www.ampiopharma.com. The company can be reached via phone at (720) 437-6500, via email at info@ampiopharma.com, or via fax at 720-437-6501.

This page (NYSE:AMPE) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -